Schedule Online Admission Counselling Meeting with Us
Apply Now - 2026

    Academic Calendar-B. Pharm - 2025-2026 Click here   B.Pharm.Management Quota / NRI Sponsored Seats Admission Year: 2025-2026 Click here

    Academic Calendar-B. Pharm - 2025-2026 Click here   B.Pharm.Management Quota / NRI Sponsored Seats Admission Year: 2025-2026 Click here

Award Image
Award Image
Award Image
Award Image
Award Image
Award Image
Award Image
Award Image
Award Image
Award Image
Profile Image
Mr.Maulik Gandhi
Education Qualification

Bachelor of Pharmacy

Master of Pharmacy (Pharmacology)

Designation
Assistant Professor
Experience
17 Years
Email
mng01@ganpatuniversity.ac.in
Department
Pharmacology
Research Area

Screening of Transient Receptor Potential Vannilloid-1 (TRPV1), TRPV3 & TRPA1 antagonists for indication of

pain

● Executing screening (Invivo) NCE of:

o CFA induced thermal (Hargreave’s method) hyperalgesia

o CFA induced mechanical (Randall selitto method) hyperalgesia


o Capsaicin induced hypothermia

● Investigated NCE’s in model of osteoarthritis (Monosodium iodoacetate induced osteoarthritis in rats)

● Tested antagonists in pSNL, CCI, SNL and Formalin paw licking pain models

● Performing exvivo screening of these NCE using capsaicin induced rat urinary bladder contraction

Investigation of PDE4, RORγt and NLRP3 inhibitors for potential effects in rheumatoid arthritis, inflammatory and

neuropathic pain

● Developing animal models of arthritis:

o Collagen Induced Arthritis (CIA) in male DBA1/J mice and female Lewis rats

o Adjuvant induced arthritis model in female Lewis rats

o Carrageenan induced air pouch model of inflammation

Investigation of NLRP3 Inhibitors in EAE model of Multiple Sclerosis

● Developing EAE model of Multiple Sclerosis:

o Standardisation and Validation of Experimental Autoimmune Encephalomyelitis in C57BL/6J mice

o Cytokine estimation in spinal cord of EAE mice by ELISA

o Flow cytometric analysis of T cell infiltration in spinal cord of EAE mice

Screening of cannabinoid 2 (CB2) agonists for the indication of pain

● Screening NCE’s (Invitro) by receptor binding assay in rat and mouse spleen membrane for its affinity towards CB2

receptor

● Investigating activity of NCE using various inflammatory and neuropathic pain models like CFA and CCI induced

mechanical hyperalgesia in rats

● Evaluating activities in CIA and carrageenan air pouch models

Investigation of RORγt inhibitors for potential effects in chronic obstructive pulmonary disease

● Developing animal models of COPD:

o Viral COPD exacerbation: CS + Poly IC induced COPD exacerbation in female C57BL/6J mice

o Acute cigarette smoke induced pulmonary inflammation in female C57BL/6J mice

o LPS induced pulmonary inflammation in female Balb/c mice and female SD rats

o Anti-CD3 antibody induced IL-17 in male C57BL/6J mice

Screening of PDE10A inhibitors for Schizophrenia

● Spearheading:

o Apomorphine induced hypothermia in mice

o Apomorphine induced climbing behaviour in mice

o Apomorphine induced stereotypic behaviour in rats

o Quipazine induced head twitches in rats

o MK 801 induced psychosis behaviour in rats

o Assessment of cataleptic behaviour in rats

o Conditioned Avoidance Response in rats

o cGMP and cAMP estimation in striatum and hippocampus regions of rat brain

Biomarker Estimation and ELISA Assays

● Managing:

o IL-1β estimation in paw tissue of arthritic mice and rats

o IL-17 estimation in paw tissue of arthritic mice and rats

Safety Pharmacological Studies

Testing the NCE’s in various safety pharmacological model

● Rota rod test in rats

● Change in rectal temperature of rats and mice

● Tail flick test for rats and mice

● Hot plate test for mice

Profile

Development & Validation of Syngeneic CT26 Model in Balb/c mice.

o Flow cytometry characterization of CT26 model

o Estimation of IL-2 & IFN-γ in tumor tissue in CT26 Model by ELISA

o Screening & Evaluation of NCEs in CT26 Tumor Model.